Ads
related to: does enzalutamide extend life expectancy- Safety Information
Visit Site to View Important
Safety Information About XTANDI.
- Clinical Results
View Clinical Results and
Information About XTANDI.
- Clinical Glossary
Need Help Decoding Medical Words?
Our Clinical Glossary Can Help.
- Downloadable Resources
Browse Helpful Resources
for Patients and Caregivers.
- Safety Information
Search results
Results from the WOW.Com Content Network
Enzalutamide, sold under the brand name Xtandi, is a nonsteroidal antiandrogen (NSAA) medication which is used in the treatment of prostate cancer. [2] [9] It is indicated for use in conjunction with castration in the treatment of metastatic castration-resistant prostate cancer (mCRPC), [2] nonmetastatic castration-resistant prostate cancer, [2] and metastatic castration-sensitive prostate ...
[3] [4] [2] N-Desmethylenzalutamide is formed from enzalutamide in the liver by the cytochrome P450 enzymes CYP2C8 and CYP3A4. [4] It has a longer terminal half-life than enzalutamide (7.8 days versus 5.8 days).
Relative to enzalutamide and apalutamide, shows greater efficacy as an AR antagonist, improved activity against mutated AR variants in prostate cancer, little or no inhibition or induction of cytochrome P450 enzymes, and little or no central nervous system distribution. However, has a much shorter terminal half-life and lower potency.
Extend health span by reducing the risk of disease at the end of life Be tested for safety and efficacy on hundreds, possibly thousands of people in clinical trials Influence all-cause mortality
At the turn of the 20th Century, one could expect to live until 47 in the U.S. Now, medical advancements, like vaccines and antibiotics, and public health initiatives have increased life ...
Life expectancy may be plateauing. Don’t expect your grandkids to live to 200 years old. A study published on Monday suggests we may be reaching our limit in terms of life expectancy and that ...
While six out of ten were willing to consider a trade-off between life expectancy and intact sexual function, given the present knowledge of treatment benefits for clinically localized prostate cancer, four out of ten stated that they would under all circumstances choose treatment irrespective of the risk for waning sexual function.
Enzalutamide, along with the in-development apalutamide and darolutamide, are newer, second-generation NSAAs. [60] Similarly to bicalutamide and the other first-generation NSAAs , they possess the same core mechanism of action of selective AR antagonism but are thought to bind to the androgen receptor with higher affinity, prevent nuclear ...
Ads
related to: does enzalutamide extend life expectancy